Related Experiment Video
Updated: Dec 6, 2025
Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
The Effects of Silver Sulfadiazine on Methicillin-Resistant Staphylococcus aureus Biofilms
Yutaka Ueda1, Motoyasu Miyazaki2, Kota Mashima1
1Department of Pharmacy, Fukuoka University Hospital, Fukuoka 814-0180, Japan.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA), the most commonly detected drug-resistant microbe in hospitals, adheres to substrates and forms biofilms that are resistant to immunological responses and antimicrobial drugs. Currently, there is a need to develop alternative approaches for treating infections caused by biofilms to prevent delays in wound healing. Silver has long been used as a disinfectant, which is non-specific and has relatively low cytotoxicity. Silver sulfadiazine (SSD) is a chemical complex clinically used for the prevention of wound infections after injury. However, its effects on biofilms are still unclear. In this study, we aimed to analyze the mechanisms underlying SSD action on biofilms formed by MRSA. The antibacterial effects of SSD were a result of silver ions and not sulfadiazine. Ionized silver from SSD in culture media was lower than that from silver nitrate; however, SSD, rather than silver nitrate, eradicated mature biofilms by bacterial killing. In SSD, sulfadiazine selectively bound to biofilms, and silver ions were then liberated. Consequently, the addition of an ion-chelator reduced the bactericidal effects of SSD on biofilms. These results indicate that SSD is an effective compound for the eradication of biofilms; thus, SSD should be used for the removal of biofilms formed on wounds.
Insights
Silver sulfadiazine effectively eradicates mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms. The compound
Area of Science:
- Microbiology
- Infectious Diseases
- Wound Healing
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) forms biofilms resistant to treatments.
- Developing new strategies to combat MRSA biofilms is crucial for wound healing.
- Silver sulfadiazine (SSD) is used for wound infection prevention, but its anti-biofilm mechanisms are unclear.
Purpose of the Study:
- To investigate the mechanisms by which SSD affects MRSA biofilms.
- To determine if silver ions or sulfadiazine are responsible for SSD's anti-biofilm activity.
Main Methods:
- Comparing SSD with silver nitrate in eradicating mature MRSA biofilms.
- Investigating the role of sulfadiazine binding to biofilms.
- Assessing the impact of ion-chelators on SSD's efficacy.
Main Results:
- SSD eradicated mature MRSA biofilms, while silver nitrate did not.
- Sulfadiazine in SSD selectively binds to biofilms, releasing silver ions.
- Ion-chelators significantly reduced SSD's bactericidal effect on biofilms, confirming the role of silver ions.
Conclusions:
- SSD is effective in eradicating mature MRSA biofilms.
- The anti-biofilm activity of SSD is primarily due to silver ion release facilitated by sulfadiazine.
- SSD is a promising agent for removing MRSA biofilms from wounds.
